• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类乳腺肿瘤中的蛋白酶和唾液酸转移酶

Proteinases and sialyltransferase in human breast tumors.

作者信息

Abecassis J, Collard R, Eber M, Pusel J, Fricker J P, Methlin G

出版信息

Int J Cancer. 1984 Jun 15;33(6):821-4. doi: 10.1002/ijc.2910330617.

DOI:10.1002/ijc.2910330617
PMID:6329971
Abstract

Proteolytic and sialyltransferase activities were determined in extracts of 65 human primary breast tumors, 6 lymph node metastases, 6 fibroadenomas and 27 normal tissues. Using proteins and synthetic selective substrates, we observed the presence of collagen-peptidases, plasminogen activator, cathepsin-B and cathepsin-D-like enzymes, and sialyltransferase. No active or trypsin-activatable type-IV collagenase activity was detected. Although individual variations between tumors were large, proteinase and sialyltransferase contents were significantly elevated in malignant breast tissues. Enzyme activities were found to be related to the epithelial volume of the tumor. No significant correlation was found between the proteinase or sialyltransferase activities and the degree of differentiation of the tumor cells, or the degree to which tumors had metastasized to regional lymph nodes. Since large variations of enzyme levels apparently reflect the heterogeneity of epithelial cell densities in tumor samples, proteolytic or sialyltransferase activities cannot therefore be used as a measure of quantitative evaluation of invasive properties in breast cancer.

摘要

在65例原发性人类乳腺肿瘤、6例淋巴结转移瘤、6例纤维腺瘤和27例正常组织的提取物中测定了蛋白水解酶和唾液酸转移酶活性。使用蛋白质和合成选择性底物,我们观察到了胶原肽酶、纤溶酶原激活剂、组织蛋白酶B和组织蛋白酶D样酶以及唾液酸转移酶的存在。未检测到活性或可被胰蛋白酶激活的IV型胶原酶活性。尽管肿瘤之间的个体差异很大,但恶性乳腺组织中的蛋白酶和唾液酸转移酶含量显著升高。发现酶活性与肿瘤的上皮体积有关。蛋白酶或唾液酸转移酶活性与肿瘤细胞的分化程度或肿瘤转移至区域淋巴结的程度之间未发现显著相关性。由于酶水平的巨大差异显然反映了肿瘤样本中上皮细胞密度的异质性,因此蛋白水解酶或唾液酸转移酶活性不能用作评估乳腺癌侵袭性的定量指标。

相似文献

1
Proteinases and sialyltransferase in human breast tumors.人类乳腺肿瘤中的蛋白酶和唾液酸转移酶
Int J Cancer. 1984 Jun 15;33(6):821-4. doi: 10.1002/ijc.2910330617.
2
Secretion of proteinases from malignant and nonmalignant human breast tissue.来自恶性和非恶性人类乳腺组织的蛋白酶分泌。
Cancer Res. 1980 Mar;40(3):550-6.
3
Cathepsins B, H and L in human breast carcinoma.人乳腺癌中的组织蛋白酶B、H和L
Eur J Clin Chem Clin Biochem. 1992 Feb;30(2):69-74.
4
The role of a cathepsin D-like activity in the release of Gal beta 1-4GlcNAc alpha 2-6-sialyltransferase from rat liver Golgi membranes during the acute-phase response.组织蛋白酶D样活性在急性期反应期间大鼠肝脏高尔基体膜释放β1-4半乳糖基-N-乙酰葡糖胺α2-6-唾液酸转移酶中的作用
Biochem J. 1988 Dec 1;256(2):623-31. doi: 10.1042/bj2560623.
5
Release of sialyltransferases from rat liver Golgi membranes by a cathepsin D-like proteinase: comparison of the release of Gal beta 1-4GlcNAc alpha 2-6 sialyltransferase, Gal beta 1-3(4)GlcNAc alpha 2-3 sialyltransferase and lactosylceramide alpha 2-3 sialyltransferase (SAT-1).
Comp Biochem Physiol B Biochem Mol Biol. 1995 Feb;110(2):445-50. doi: 10.1016/0305-0491(94)00149-o.
6
Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis.人乳腺癌中产生组织蛋白酶D、B和L的细胞及其与预后的关系。
Hum Pathol. 2000 Feb;31(2):149-60. doi: 10.1016/s0046-8177(00)80214-2.
7
Cystatins and cathepsins in breast carcinoma.乳腺癌中的胱抑素和组织蛋白酶
Biol Chem Hoppe Seyler. 1992 Jul;373(7):595-604. doi: 10.1515/bchm3.1992.373.2.595.
8
Identification and functional characterization of a human GalNAc [alpha]2,6-sialyltransferase with altered expression in breast cancer.一种在乳腺癌中表达改变的人GalNAcα2,6-唾液酸转移酶的鉴定及功能表征
Mol Med. 2002 Jan;8(1):42-55.
9
Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas.人乳腺癌和纤维腺瘤边缘组织中蛋白酶组织蛋白酶B分泌的差异。
Nature. 1978 Jun 15;273(5663):545-7. doi: 10.1038/273545a0.
10
Are proteinase inhibitors potentially useful in tumor therapy?蛋白酶抑制剂在肿瘤治疗中可能有用吗?
Invasion Metastasis. 1982;2(2):113-24.

引用本文的文献

1
Tumour-associated carbohydrate antigens in breast cancer.乳腺癌相关的肿瘤碳水化合物抗原。
Breast Cancer Res. 2010;12(3):204. doi: 10.1186/bcr2577. Epub 2010 Jun 8.
2
Cathepsin D in primary breast carcinoma: adverse prognosis is associated with expression of cathepsin D in stromal cells.原发性乳腺癌中的组织蛋白酶D:不良预后与基质细胞中组织蛋白酶D的表达相关。
Breast Cancer Res Treat. 1995;33(2):137-45. doi: 10.1007/BF00682721.
3
Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours.
恶性与良性乳腺肿瘤中组织蛋白酶D、尿激酶和纤溶酶原激活物抑制剂之间的关系
Br J Cancer. 1991 Nov;64(5):926-32. doi: 10.1038/bjc.1991.428.